WHICH TEST TO USE FOR DETERMINATION OF CLARITHROMYCIN AND LEVOFLOXACIN SUSCEPTIBILITY IN HELICOBACTER PYLORI INFECTION?

被引：0
|
作者：
Becerikli, T. [1 ]
Yilmaz, O. [1 ]
Demiray-Gurbuz, E. [1 ]
Soyturk, M. [2 ]
Ellidokuz, H. [3 ]
Simsek, I. [2 ]
机构：
[1] Dokuz Eylul Univ, Fac Med, Dept Med Microbiol, Izmir, Turkey
[2] Dokuz Eylul Univ, Fac Med, Dept Gastroenterol, Izmir, Turkey
[3] Dokuz Eylul Univ, Fac Med, Dept Biostat & Med Informat, Izmir, Turkey
来源：
HELICOBACTER | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P13.09
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [41] Levofloxacin in first-line treatment of Helicobacter pylori infection
    Rispo, A.
    Di Girolamo, E.
    Cozzolino, A.
    Bozzi, R.
    Morante, A.
    Pasquale, L.
    HELICOBACTER, 2007, 12 (04) : 364 - 365
  • [42] Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of Helicobacter pylori Infection
    Liu, Ligang
    Nahata, Milap C.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (10) : 1185 - 1197
  • [43] Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection
    Talley, NJ
    Full-Young, C
    Wyatt, JMA
    Adams, S
    Lau, A
    Borody, T
    Tseng-Shing, C
    Daskolopolos, G
    Cheung, K
    Talley, NA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (06) : 527 - 532
  • [44] Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection
    Harris, AW
    Pryce, DI
    Gabe, SM
    Karim, QN
    Walker, MM
    Langworthy, H
    Baron, JH
    Misiewicz, JJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (06) : 1005 - 1008
  • [45] Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin
    Tompkins, DS
    Perkin, J
    Smith, C
    HELICOBACTER, 1997, 2 (04) : 185 - 187
  • [46] Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
    Aftab, Hafeza
    Miftahussurur, Muhammad
    Subsomwong, Phawinee
    Ahmed, Faruque
    Khan, A. K. Azad
    Yamaoka, Yoshio
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (03): : 245 - 253
  • [47] Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin
    Yonezawa, Hideo
    Osaki, Takako
    Hojo, Fuhito
    Kamiya, Shigeru
    MICROBIAL PATHOGENESIS, 2019, 132 : 100 - 108
  • [48] Impact of Helicobacter pylori eradication regimen tailored for clarithromycin susceptibility in Japan
    Kawai, T.
    Yamagishi, T.
    Kataoka, M.
    Tamura, R.
    Rimbara, E.
    Noguchi, N.
    Sasatsu, M.
    HELICOBACTER, 2006, 11 (04) : 387 - 387
  • [49] Metronidazole and clarithromycin susceptibility and the subtypes of VacA of Helicobacter pylori isolates in Estonia
    Loivukene, K
    Kolk, H
    Maaroos, HI
    Kasenomm, P
    Aro, H
    Ustav, M
    Mikelsaar, M
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2000, 32 (01) : 59 - 62
  • [50] In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole
    Loo, VG
    Fallone, CA
    De Souza, E
    Lavallée, J
    Barkun, AN
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (06) : 881 - 883
12345